Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community

British Journal of Clinical Pharmacology
Arduino A MangoniKathleen M Knights


We studied the association between either non-selective NSAIDs (ns-NSAIDs), selective COX-2 inhibitors, or any NSAID and risk of incident myocardial infarction (MI) and heart failure (HF), and all-cause mortality in elderly subjects. We conducted a retrospective nested case-control study on Australian veterans using nationwide hospital admission and pharmacy dispensing data. We estimated adjusted odds ratios (OR) with 95% confidence intervals (CI) for the risk of events for three different measures of prescription supply exposure over the last 2 years: (i) supplied at least once, (ii) supply frequency: supplied more than twice within the last 30 days, once or twice within the last 30 days, and once or more 30 days to 2 years and (iii) total supplies. We identified 83 623 cases and 1 662 099 matched controls (1:20) contributing 3 862 931 persons-years of observation. NSAID use at least once within the last 2 years did not significantly affect the risk of MI (OR 1.00, 95% CI 0.96, 1.04) but was associated with a mildly reduced risk of HF (OR 0.95, 95% CI 0.92, 0.98). There was a reduced all-cause mortality with at least one supply of either ns-NSAIDs (OR 0.94, 95% CI 0.90, 0.97), selective COX-2 inhibitors (OR 0.90, 95% CI 0.88, ...Continue Reading


Apr 1, 1988·British Journal of Pharmacology·R M Tripathi, R Kaushal
Apr 18, 1994·Annals of the New York Academy of Sciences·W L SmithD L DeWitt
May 30, 1998·Archives of Internal Medicine·Eibert R HeerdinkA Bakker
Jun 23, 1999·Proceedings of the National Academy of Sciences of the United States of America·T D WarnerJ R Vane
Aug 31, 2001·JAMA : the Journal of the American Medical Association·D MukherjeeE J Topol
Oct 13, 2001·Circulation Research·S T Davidge
May 22, 2002·Archives of Internal Medicine·Daniel H SolomonJerry Avorn
Aug 21, 2002·Statistics in Medicine·Gary King, Langche Zeng
Sep 19, 2002·British Journal of Clinical Pharmacology·Raymond G SchliengerChristoph R Meier
Feb 28, 2003·Epidemiology·Luis Alberto García Rodríguez, Sonia Hernández-Díaz
Oct 18, 2003·American Heart Journal·Vidal EssebagLouise Pilote
Nov 19, 2003·Circulation·Ronnier J AvilesMina K Chung
Mar 17, 2004·Heart·Stefan D Anker, Stephan von Haehling
Apr 6, 2004·Current Opinion in Pharmacology·Akira Matsumori
Jun 16, 2004·Circulation·Luis Alberto García RodríguezAntonio González-Pérez
Oct 8, 2004·The New England Journal of Medicine·Garret A Fitzgerald
Feb 3, 2005·Annals of Internal Medicine·Stephen E KimmelBrian L Strom
Feb 16, 2005·Archives of Internal Medicine·Tai-Juan AwHenry Krum
Dec 1, 2005·BMC Medicine·Luis Alberto García Rodríguez, Antonio González-Pérez
Jan 5, 2006·Pharmacoepidemiology and Drug Safety·Priscilla VelentgasAlexander M Walker
Apr 6, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Irmgard Tegeder, Gerd Geisslinger
Aug 23, 2006·American Heart Journal·Isabella KardysJacqueline C M Witteman
Sep 14, 2006·JAMA : the Journal of the American Medical Association·Jingjing ZhangYiqing Song
Oct 31, 2006·European Journal of Epidemiology·Eunhee KimChol Shin
Nov 30, 2006·Current Opinion in Hematology·Kevin Croce, Peter Libby
Dec 5, 2006·International Journal of Cardiology·Wei YueWojciech Zareba
Jan 9, 2007·The American Journal of Medicine·Todd A LeeKevin B Weiss
Feb 16, 2007·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Christin HeidemannHeiner Boeing
Apr 7, 2007·Annals of the Rheumatic Diseases·Michael E FarkouhS B Abramson
Apr 18, 2007·Current Rheumatology Reports·William B White
May 29, 2007·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Hugues BlangyFaiez Zannad
Jun 7, 2007·Journal of the National Cancer Institute·Aditya BardiaJames R Cerhan
Nov 13, 2007·Current Opinion in Lipidology·Sami P MoubayedJean-Claude Tardif
Jan 5, 2008·Current Pain and Headache Reports·William B White
Mar 25, 2008·Acta Pharmacologica Sinica·Zhi-fang YangCi-zhen Li
Apr 3, 2008·Pharmacoepidemiology and Drug Safety·Emil L FosbølChristian Torp-Pedersen
Apr 4, 2008·British Journal of Clinical Pharmacology·Patricia McGettiganDavid Henry
Jul 16, 2008·Journal of Internal Medicine·T-P van StaaH G M Leufkens
Aug 2, 2008·Journal of the American College of Cardiology·Jing FangNora L Keenan
Oct 25, 2008·The American Journal of Pathology·Brian D Lamon, David P Hajjar
Nov 11, 2008·Journal of the American College of Cardiology·Luis Alberto García RodríguezPaola Patrignani
Jan 7, 2009·Therapeutic Advances in Cardiovascular Disease·Ashish Aneja, Michael E Farkouh
Apr 25, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rhema VaithianathanDavid W Bates


Apr 25, 2012·European Journal of Clinical Pharmacology·Jean-Pascal FournierJean-Louis Montastruc
Jul 23, 2014·Maturitas·Helen GaskellR Andrew Moore
Nov 6, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Patrick B RyanAbraham G Hartzema
Nov 22, 2013·Expert Opinion on Drug Safety·Nicholas MooreAntoine Pariente
May 9, 2014·Current Medical Research and Opinion·David A Provenzano, Eugene R Viscusi
Feb 1, 2011·British Journal of Clinical Pharmacology·Stephen J KerrAndrea Mant
Aug 15, 2013·Pain Practice : the Official Journal of World Institute of Pain·Robert Andrew MoorePaul Emery
Mar 8, 2013·Pain Practice : the Official Journal of World Institute of Pain·R AndrewCeri J Phillips
Apr 25, 2015·International Journal of Clinical Practice. Supplement·R Andrew Moore
Oct 3, 2015·European Journal of Internal Medicine·Patompong UngprasertWonngarm Kittanamongkolchai
Aug 31, 2016·Expert Review of Clinical Pharmacology·Gerhard ZinglerThomas Herdegen
Mar 30, 2017·The Cochrane Database of Systematic Reviews·Sheena DerryR Andrew Moore
Jul 13, 2017·The Cochrane Database of Systematic Reviews·Sheena DerryBee Wee
Nov 9, 2016·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Dominick J Angiolillo, Steven M Weisman
Oct 17, 2017·Rheumatology International·Deepan DalalDavid Felson
Nov 9, 2011·The Medical Journal of Australia·Gillian E CaugheyAndrew L Gilbert
Apr 11, 2019·Current Clinical Pharmacology·Arduino A MangoniElzbieta A Jarmuzewska

Related Concepts

Analgesics, Anti-Inflammatory
Cause of Death
Myocardial Failure
Myocardial Infarction
Retrospective Studies
Logistic Regression
Nested Case-Control Studies
Cyclooxygenase 2 Inhibitors
Anti-Inflammatory Agents, Non-Steroidal

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

The Tendon Seed Network

Tendons are rich in the extracellular matrix and are abundant throughout the body providing essential roles including structure and mobility. The transcriptome of tendons is being compiled to understand the micro-anatomical functioning of tendons. Discover the latest research pertaining to the Tendon Seed Network here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.


Incretins are metabolic hormones that stimulate a decrease in glucose levels in the blood and they have been implicated in glycemic regulation in the remission phase of type 1 diabetes. Here is the latest research.

Chromatin Regulation and Circadian Clocks

The circadian clock plays an important role in regulating transcriptional dynamics through changes in chromatin folding and remodelling. Discover the latest research on Chromatin Regulation and Circadian Clocks here.

Long COVID-19

“Long Covid-19” describes illness in patients who are reporting long-lasting effects of the SARS-CoV-19 infection, often long after they have recovered from acute Covid-19. Ongoing health issues often reported include low exercise tolerance and breathing difficulties, chronic tiredness, and mental health problems such as post-traumatic stress disorder and depression. This feed follows the latest research into Long Covid.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.